BWXT's main risk is pacing, not relevance. The moat is real because licensed nuclear capacity, trust and qualification are hard to replace, but returns from here depend on government funding cadence, regulatory timing, supplier resilience,
PCG integration and whether commercial nuclear demand converts into high-quality
backlog quickly enough to justify an already premium starting valuation.